Oncology Is a Team Sport: ASCO Panel Highlights Multidisciplinary Collaboration

Explore the latest breakthroughs from the 2025 ASCO Annual Meeting with two leading experts in oncology, Dr. Mark Lewis and Dr. Stephanie Graff. This discussion highlights the significant progress in biomarker-driven cancer care and addresses key topics in translational research. This video dives into the most impactful presentations from ASCO, including new data on antibody-drug conjugates and the role of circulating tumor DNA (ctDNA) as a prognostic tool. The doctors also discuss the importance of integrating new therapeutic approaches, the challenges of modern clinical trial design, and the evolving role of pathology in personalized medicine. #ASCO2025 #Oncology #CancerResearch #BreastCancer #GIOncology #Biomarkers #ClinicalTrials #PrecisionMedicine 00:00 - Introduction to the ASCO Annual Meeting 00:25 - The Super Bowl of Oncology 01:08 - Exciting Updates in Breast Oncology 02:37 - The Role of Circulating Tumor DNA 05:43 - The Importance of Biomarkers 09:07 - Challenges in Clinical Trial Design https://www.medscape.com/viewarticle/...